ARTICLE | Company News
Aptanomics SA, Boehringer Ingelheim deal
August 8, 2005 7:00 AM UTC
Aptanomics will provide Boehringer with a panel of peptide aptamers for validating BI's targets and identifying druggable sites. Financial terms were not disclosed. ...